Found: 6
Select item for more details and to access through your institution.
Mitochondrial dysfunction and immune suppression in BRAF V600E‐mutated metastatic melanoma.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 7, p. 1, doi. 10.1002/ctm2.1773
- By:
- Publication type:
- Article
The human melanoma proteome atlas—Defining the molecular pathology.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 7, p. 1, doi. 10.1002/ctm2.473
- By:
- Publication type:
- Article
The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 7, p. 1, doi. 10.1002/ctm2.451
- By:
- Publication type:
- Article
The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1712, doi. 10.3390/cancers15061712
- By:
- Publication type:
- Article
Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5984, doi. 10.3390/cancers13235984
- By:
- Publication type:
- Article
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1428182
- By:
- Publication type:
- Article